ArticleJournal of cancer research and clinical oncology2023

Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization.

Wenzhe Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.